MedTrace Logo

P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer

NCT05542940 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-09-16

No results posted yet for this study

Summary

Objective: Calculate the incidence of P53 immunohistochemistry abnormal staining in endometrial cancer and to identify its relation with disease stages, pathological types and grading.

Patients and methods:

100 cases of endometrial cancer will be included in the study, recruited from Alexandria university hospital gyne-oncology unit. Surgical staging, histopathological examination and immunohistochemistry of p53 were done to all cases to calculate the incidence of P53 immunohistochemistry abnormal staining in endometrial cancer and to identify its relation with disease stages, pathological types, grading.

Keywords: P53 immunohistochemistry, endometrial cancer, clinicopathological relation.

Conditions

Interventions

OTHER

p 53 immunohistochemistry positive staining and relation to stages ,pathological types and grading

p 53 immunohistochemistry positive staining and relation to stages ,pathological types and grading

Sponsors & Collaborators

  • Hossam Hassan Aly Hassan El Sokkary

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2022-08-31
Completion
2022-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05542940 on ClinicalTrials.gov